GSK drinks deal set to go ahead

 
Kasmira Jefford
Follow Kasmira
PHARMACEUTICALS firm GlaxoSmithKline (GSK) is expected to announce as soon as today that it has struck a deal to sell its soft drinks Ribena and Lucozade to Japan’s Suntory Food and Beverage. The two firms are reported to have reached an agreement that would see the two brands sold to Suntory for £1.3bn. GSK announced plans in April to sell Lucozade and Ribena.

Both GlaxoSmithKline and Suntory declined to comment last night.